赛诺菲制药公司的丹尼斯尔班尼亚克(Dennis Ur baniak)说：“这是一个慢性，渐进的情况。”
Dennis Urbaniak, of pharmaceutical firm Sanofi, said: "This is a chronic, progressive condition."
法国制药公司赛诺菲-安万特也在就一种口服药物特立氟胺开展大型临床试验。
France's Sanofi-Aventis is carrying out large clinical trials of an oral drug called teriflunomide.
法国制药公司赛诺菲-安万特同时也在就自己的治疗多发性硬化症的口服药物teriflunomide的大型临床试验。
France's Sanofi-Aventis SA, meanwhile, is carrying out large clinical trials of an oral MS drug called teriflunomide.
这类药物包括雅培制药公司的利普安、阿斯利康公司的高舍瑞林和赛诺菲·安万特集团的醋酸亮丙瑞林。
The medications include Abbott Laboratories inc's Lupron, AstraZeneca Plc's Zoladex and Sanofi-Aventis SA's Eligard.
赛诺菲，作为世界第三大制药公司，在中国已经有一个重要的商业地位，并正在进行多项临床试验。
Sanofi, the world's third-largest drugmaker, already has a significant commercial presence in China and is conducting many clinical trials in the country.
赛诺菲，作为世界第三大制药公司，在中国已经有一个重要的商业地位，并正在进行多项临床试验。
Sanofi, the world's third-largest drugmaker, already has a significant commercial presence in China and is conducting many clinical trials in the country.
应用推荐